These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 19574400)

  • 1. Minireview: epigenetic changes in ovarian cancer.
    Balch C; Fang F; Matei DE; Huang TH; Nephew KP
    Endocrinology; 2009 Sep; 150(9):4003-11. PubMed ID: 19574400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetics in ovarian cancer.
    Seeber LM; van Diest PJ
    Methods Mol Biol; 2012; 863():253-69. PubMed ID: 22359298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer.
    Balch C; Nephew KP
    Cancer Biomark; 2010-2011; 8(4-5):203-21. PubMed ID: 22045354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of cancer-associated genes in ovarian cancer.
    Kwon MJ; Shin YK
    Int J Mol Sci; 2011 Jan; 12(2):983-1008. PubMed ID: 21541038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes.
    Matei D; Nephew KP
    Cancer Res; 2020 Sep; 80(18):3775-3785. PubMed ID: 32381656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.
    Pajares MJ; Alemany-Cosme E; Goñi S; Bandres E; Palanca-Ballester C; Sandoval J
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer.
    Borley J; Brown R
    Ann Med; 2015; 47(5):359-69. PubMed ID: 26158617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SiRNA and epigenetic aberrations in ovarian cancer.
    Mirzaei H; Yazdi F; Salehi R; Mirzaei HR
    J Cancer Res Ther; 2016; 12(2):498-508. PubMed ID: 27461600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics in ovarian cancer: premise, properties, and perspectives.
    Yang Q; Yang Y; Zhou N; Tang K; Lau WB; Lau B; Wang W; Xu L; Yang Z; Huang S; Wang X; Yi T; Zhao X; Wei Y; Wang H; Zhao L; Zhou S
    Mol Cancer; 2018 Jul; 17(1):109. PubMed ID: 30064416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of epigenomics in ovarian and endometrial cancers.
    Balch C; Matei DE; Huang TH; Nephew KP
    Epigenomics; 2010 Jun; 2(3):419-47. PubMed ID: 22121902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current data and future perspectives on DNA methylation in ovarian cancer (Review).
    Fu M; Deng F; Chen J; Fu L; Lei J; Xu T; Chen Y; Zhou J; Gao Q; Ding H
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational application of epigenetic alterations: ovarian cancer as a model.
    Maradeo ME; Cairns P
    FEBS Lett; 2011 Jul; 585(13):2112-20. PubMed ID: 21402071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications in prostate cancer.
    Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
    Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
    Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
    Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Epigenetic Drug Targeting of Heterogenous Tumor Cell Fractions Using Potential Biomarkers of Response in Ovarian Cancer.
    Singh AK; Chandra N; Bapat SA
    Clin Cancer Res; 2015 Nov; 21(22):5151-63. PubMed ID: 26130461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic biomarkers in epithelial ovarian cancer.
    Gloss BS; Samimi G
    Cancer Lett; 2014 Jan; 342(2):257-63. PubMed ID: 22245949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of epigenetic alterations in lung carcinogenesis.
    Brzeziańska E; Dutkowska A; Antczak A
    Mol Biol Rep; 2013 Jan; 40(1):309-25. PubMed ID: 23086271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New anti-cancer strategies: epigenetic therapies and biomarkers.
    Balch C; Montgomery JS; Paik HI; Kim S; Kim S; Huang TH; Nephew KP
    Front Biosci; 2005 May; 10():1897-931. PubMed ID: 15769674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.